![]() |
JOURNAL TOOLS |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Estratti |
Permessi |

I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
BIOLOGICAL IMAGES
Minerva Biotecnologica 2004 December;16(4):289-97
Copyright © 2005 EDIZIONI MINERVA MEDICA
lingua: Inglese
Medical progress in Helicobacter pylori: Genomics at the rescue
Pellicano R. 1, Ponzetto A. 1, 2, Smedile A. 1, 2, Rizzetto M. 1, 2
1 Department of Gastro-Hepatology, Molinette Hospital, Turin, Italy; 2 Department of Internal Medicine, University of Turin, Turin, Italy
Helicobacter pylori (H. pylori) infection represents the major causal agent of several acute and chronic gastroduodenal diseases including peptic ulcer, gastric carcinoma, and mucosa-associated lymphoid tissue lymphoma. Moreover, this bacterium has been involved in many extragastric manifestations. As genomic techniques improve and become more readily available, researchers are able to solve some of the unexplained issues of H. pylori pathogenesis. To date it is possible to discover the function of hundreds of gene products and gain insight into posttranslational modification through proteomics. These consent to improve our understanding concerning its interaction with the host, genetic diversity and the mechanism underlying its evolution and adaptive potential.